Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8854)
All Articles published online
|
Publishing Process of This Article
|
May 21, 2016 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Song ZQ, Zhou LY. Hybrid, sequential and concomitant therapies for Helicobacter pylori eradication: A systematic review and meta-analysis. World J Gastroenterol 2016; 22(19): 4766-4775 [PMID: 27217708 DOI: 10.3748/wjg.v22.i19.4766] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i19/4766.htm |
| Number | Citing Articles |
| 1 |
Xavier Calvet. Dealing with uncertainty in the treatment of Helicobacter pylori. Therapeutic Advances in Chronic Disease 2018; 9(4): 93 doi: 10.1177/2040622318758240
|
| 2 |
Zhiqiang Song, Baojun Suo, Xueli Tian, Xinlu Ren, Yan Xue, Zhanyue Niu, Liya Zhou. Tailored triple plus bismuth therapy based on previous antibiotic medication history for first-line Helicobacter pylori eradication: A randomized trial. Digestive and Liver Disease 2023; 55(5): 601 doi: 10.1016/j.dld.2022.12.019
|
| 3 |
Olga P Nyssen, Dmitry Bordin, Bojan Tepes, Ángeles Pérez-Aisa, Dino Vaira, Maria Caldas, Luis Bujanda, Manuel Castro-Fernandez, Frode Lerang, Marcis Leja, Luís Rodrigo, Theodore Rokkas, Limas Kupcinskas, Jorge Pérez-Lasala, Laimas Jonaitis, Oleg Shvets, Antonio Gasbarrini, Halis Simsek, Anthony T R Axon, György Buzás, Jose Carlos Machado, Yaron Niv, Lyudmila Boyanova, Adrian Goldis, Vincent Lamy, Ante Tonkic, Krzysztof Przytulski, Christoph Beglinger, Marino Venerito, Peter Bytzer, Lisette Capelle, Tomica Milosavljević, Vladimir Milivojevic, Lea Veijola, Javier Molina-Infante, Liudmila Vologzhanina, Galina Fadeenko, Ines Ariño, Giulia Fiorini, Ana Garre, Jesús Garrido, Cristina F Pérez, Ignasi Puig, Frederic Heluwaert, Francis Megraud, Colm O'Morain, Javier P Gisbert. European Registry onHelicobacter pylorimanagement (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients. Gut 2021; 70(1): 40 doi: 10.1136/gutjnl-2020-321372
|
| 4 |
Keliang Wang, Dandi Lou, Wei Dai, Rongrong Fu, Zhenhua Ma. Comparison of sequential therapy with concomitant therapy in first-line treatment of Helicobacter pylori: an updated meta-analysis.
Journal of Medical Microbiology
2022; 71(1) doi: 10.1099/jmm.0.001490
|
| 5 |
David Itskoviz, Doron Boltin, Haim Leibovitzh, Tsachi Tsadok Perets, Doron Comaneshter, Arnon Cohen, Yaron Niv, Zohar Levi. Smoking increases the likelihood of Helicobacter pylori treatment failure. Digestive and Liver Disease 2017; 49(7): 764 doi: 10.1016/j.dld.2017.03.010
|
| 6 |
Chih-Chieh Huang, Kuo-Wang Tsai, Tzung-Jiun Tsai, Ping-I Hsu. Update on the first-line treatment for Helicobacter pylori infection - a continuing challenge from an old enemy. Biomarker Research 2017; 5(1) doi: 10.1186/s40364-017-0103-x
|
| 7 |
Peter Malfertheiner, Francis Megraud, Theodore Rokkas, Javier P Gisbert, Jyh-Ming Liou, Christian Schulz, Antonio Gasbarrini, Richard H Hunt, Marcis Leja, Colm O'Morain, Massimo Rugge, Sebastian Suerbaum, Herbert Tilg, Kentaro Sugano, Emad M El-Omar. Management ofHelicobacter pyloriinfection: the Maastricht VI/Florence consensus report. Gut 2022; 71(9): 1724 doi: 10.1136/gutjnl-2022-327745
|
| 8 |
Jiajia Wu, Zheng Qian, Dingfu Zhong, Min Lin. The impact of secondhand smoke on failure of Helicobacter pylori therapy is not inferior to that of smoking. Clinics and Research in Hepatology and Gastroenterology 2024; 48(6): 102312 doi: 10.1016/j.clinre.2024.102312
|
| 9 |
Yoon Suk Jung, Chan Hyuk Park, Jung Ho Park, Eunwoo Nam, Hang Lak Lee. Efficacy of Helicobacter pylori eradication therapies in Korea: A systematic review and network meta‐analysis. Helicobacter 2017; 22(4) doi: 10.1111/hel.12389
|
| 10 |
Melike Arslan, Necati Balamtekin, Armağan Günal. Efficacy of a novel sequential treatment regimen containing bismuth forHelicobacter pylorieradication in Turkish children. Helicobacter 2020; 25(6) doi: 10.1111/hel.12757
|
| 11 |
Alicia C. Marin, Olga P. Nyssen, Adrian G. McNicholl, Javier P. Gisbert. Efficacy and Safety of Quinolone-Containing Rescue Therapies After the Failure of Non-Bismuth Quadruple Treatments for Helicobacter pylori Eradication: Systematic Review and Meta-Analysis. Drugs 2017; 77(7): 765 doi: 10.1007/s40265-017-0730-4
|
| 12 |
Anthony O'Connor, Dominique Lamarque, Javier P. Gisbert, Colm O'Morain. Treatment of Helicobacter pylori infection 2017. Helicobacter 2017; 22(S1) doi: 10.1111/hel.12410
|
| 13 |
Tsung-Jung Lin, Hsi-Chang Lee, Chih-Lin Lin, Chung-Kwe Wang, Kuan-Yang Chen, Deng-Chyang Wu. CYP2C19 polymorphism has no influence on rabeprazole-based hybrid therapy for <i>Helicobacter pylori</i> eradication. World Journal of Clinical Cases 2018; 6(12): 514-520 doi: 10.12998/wjcc.v6.i12.514
|
| 14 |
Salma Souissi, Cyrine Makni, Basma Chaieb, Amine Jarraya, Nadia Toulgui, Lobna Jmal, Mouna Mlika, Chadlia Fendri, Mohamed Bouchoucha, Rabie Razgallah, Leila Belhadj Ammar, Olfa Bousnina, Fawzi Mezni, Awatef Jmal, Lamia Kallel.
Eradication of
Helicobacter pylori
: a prospective comparative randomized trial of standard versus optimized quadruple therapy
. Future Science OA 2024; 10(1) doi: 10.2144/fsoa-2023-0316
|
| 15 |
Sotirios D. Georgopoulos, Elias Xirouchakis, Christos Liatsos, Pericles Apostolopoulos, Panagiotis Kasapidis, Beatriz Martinez-Gonzalez, Fotini Laoudi, Maria Stoupaki, Georgios Axiaris, Dionysios Sgouras, Andreas Mentis, Spyridon Michopoulos. Equivalence Trial of the Non-Bismuth 10-Day Concomitant and 14-Day Hybrid Therapies for Helicobacter pylori Eradication in High Clarithromycin Resistance Areas. Antibiotics 2024; 13(3): 280 doi: 10.3390/antibiotics13030280
|
| 16 |
Antonio Mestrovic, Nikola Perkovic, Josko Bozic, Mirela Pavicic Ivelja, Jonatan Vukovic, Goran Kardum, Zeljko Puljiz, Ante Tonkic, Lise Lotte Gluud. Randomised clinical trial comparing concomitant and hybrid therapy for eradication of Helicobacter pylori infection. PLOS ONE 2020; 15(12): e0244500 doi: 10.1371/journal.pone.0244500
|
| 17 |
Shivaram Prasad Singh, Vineet Ahuja, Uday C. Ghoshal, Govind Makharia, Usha Dutta, Showkat Ali Zargar, Jayanthi Venkataraman, Amit Kumar Dutta, Asish K Mukhopadhyay, Ayaskanta Singh, Babu Ram Thapa, Kim Vaiphei, Malathi Sathiyasekaran, Manoj K. Sahu, Niranjan Rout, Philip Abraham, Prakash Chandra Dalai, Pravin Rathi, Saroj K. Sinha, Shobna Bhatia, Susama Patra, Ujjala Ghoshal, Ujjal Poddar, Venigalla Pratap Mouli, Vikram Kate. Management of Helicobacter pylori infection: The Bhubaneswar Consensus Report of the Indian Society of Gastroenterology. Indian Journal of Gastroenterology 2021; 40(4): 420 doi: 10.1007/s12664-021-01186-4
|
| 18 |
Huimei Xu, Wancong Wang, Xueni Ma, Rukun Feng, Yujing Su, Long Cheng, Yifan Yang, Dekui Zhang. Comparative efficacy and safety of high-dose dual therapy, bismuth-based quadruple therapy and non-bismuth quadruple therapies for Helicobacter pylori infection: a network meta-analysis. European Journal of Gastroenterology & Hepatology 2021; 33(6): 775 doi: 10.1097/MEG.0000000000001835
|
| 19 |
Fahad Alsohaibani, Musthafa Peedikayil, Abdulaziz Alshahrani, Ali Somily, Raed Alsulaiman, Nahla Azzam, Majid Almadi. Practice guidelines for the management of Helicobacter pylori infection: The Saudi H. pylori Working Group recommendations. Saudi Journal of Gastroenterology 2023; 29(6): 326 doi: 10.4103/sjg.sjg_288_22
|
| 20 |
Javier P. Gisbert, Adrian G. McNicholl. Optimization strategies aimed to increase the efficacy of H. pylori eradication therapies. Helicobacter 2017; 22(4) doi: 10.1111/hel.12392
|
| 21 |
Jeong Hun Park, Dongwoo Kim, Jung Wan Choe, Seung Young Kim, Sung Woo Jung, Jong Jin Hyun, Young Kul Jung, Ja Seol Koo, Hyung Joon Yim, Sang Woo Lee. First-line Helicobacter pylori Eradication Rate of the 10-day Hybrid Therapy. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2020; 20(4): 300 doi: 10.7704/kjhugr.2020.0019
|
| 22 |
Ju Yup Lee, Kyung Sik Park. Optimal First-Line Treatment forHelicobacter pyloriInfection: Recent Strategies. Gastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/9086581
|